Second Genome, Inc.. (4/20/16). "Press Release: Second Genome Secures $42.6 Million in Series B Financing Led by Pfizer Venture Investments and Roche Venture Fund". South San Francisco, CA. |
2016-04-20 |
Formycon AG. (4/20/16). "Press Release: Formycon Ends 2015 Fiscal Year with Successful Results [Not for USA, Canada, Australia, Japan, et al.]". Munich. |
2016-04-20 |
Saphetor S.A.. (4/20/16). "Press Release: Saphetor Signs Collaboration with Lausanne University Hospital (CHUV)". Lausanne. |
2016-04-20 |
GlaxoSmithKline plc. (4/20/16). "Press Release: SBP and GSK Create New Center for Translational Neuroscience. Academic-Industry Alliance Seeks to Find and Validate New Targets for Drug Development". La Jolla, CA. |
2016-04-20 |
Enterome Bioscience S.A.. (4/20/16). "Press Release: Enterome Raises €14.5 Million in Series C Financing Round. Nestlé Health Science Invests alongside Existing Investors". Paris & Boston, MA. |
2016-04-20 |
TxCell S.A.. (4/20/16). "Press Release: Financial Information for the 1st Quarter of 2016". Valbonne. |
2016-04-20 |
PeptiMimesis. (4/20/16). "Press Release: PeptiMimesis Secures €1.2m ($1.4m) from Cap Innov’Est". Strasbourg. |
2016-04-20 |
Peak Scientific Instruments Ltd.. (4/20/16). "Press Release: Peak Scientific Wins Brace of Queen’s Awards for Enterprise". |
2016-04-20 |
bioMérieux S.A.. (4/20/16). "Press Release: bioMérieux – First-quarter 2016 Business Review. Solid Growth in Sales, up 11.5% at Constant Exchange Rates and Scope of Consolidation". |
2016-04-20 |
Novartis AG. (4/21/16). "Press Release: Novartis Delivered Solid Q1 Despite Gleevec Loss of Exclusivity, Investing Behind New Launches for Long-term Growth". Basel. |
2016-04-21 |
Ablynx N.V.. (4/21/16). "Press Release: Ablynx to Receive an €8 Million Milestone as Boehringer Ingelheim Starts a Phase I Study with an anti-CX3CR1 Nanobody". Ghent & Ingelheim. |
2016-04-21 |
MorphoSys AG. (4/21/16). "Press Release: MorphoSys Provides Update on Results From Partner's Phase 2b/3 RESILIENT Study of Bimagrumab. Bimagrumab Did Not Meet Its Primary Endpoint in Patients with sIBM". |
2016-04-21 |
Aptuit, LLC. (4/21/16). "Press Release: Aptuit Announces Acquisition of Exquiron Biotech AG". Greenwich, CT. |
2016-04-21 |
Illumina, Inc.. (4/21/16). "Press Release: Illumina Files Patent Infringement Suit in Switzerland against Genoma SA for Infringement of NIPT Patents". San Diego, CA. |
2016-04-21 |
SMS-Oncology (Specialized Medical Services-Oncology B.V.). (4/21/16). "Press Release: €8.3 Million EU Grant Awarded to International »PRECIOUS« Consortium to Integrate Nanomedicines and Immunotherapy to Attack Cancer". |
2016-04-21 |
Hummingbird Bioscience. (4/21/16). "Press Release: Hummingbird Bioscience and Sanofi Announce Collaboration for the Development of Novel Cancer Therapeutics". |
2016-04-21 |
iTeos Therapeutics S.A.. (4/21/16). "Press Release: €8.3 Million EU Grant Awarded to International »PRECIOUS« Consortium to Integrate Nanomedicines and Immunotherapy to Attack Cancer". Bilthoven. |
2016-04-21 |
Dassault Systèmes S.A.. (4/21/16). "Press Release: Dassault Systèmes Reports Q1 Non-IFRS Total Revenues at High End of Guidance and Reaffirms 2016 Financial Objectives". Vélizy-Villacoublay. |
2016-04-21 |
Argen-X N.V. (Argenx). (4/21/16). "Press Release: Argenx and AbbVie to Collaborate on ARGX-115 against Novel Immuno-Oncology Target". Breda, Ghent & North Chicago, IL. |
2016-04-21 |
F-Star Biotechnology Ltd.. (4/21/16). "Press Release: F-star to Present at Key Conferences in April and May 2016". Cambridge. |
2016-04-21 |
Ionicon Analytik GmbH. (4/22/16). "Press Release: Ionicon Launches Autosampler for High Throughput PTR-MS Measurements". Innsbruck. |
2016-04-22 |
AstraZeneca plc. (4/22/16). "Press Release: AstraZeneca Launches Integrated Genomics Approach to Transform Drug Discovery and Development". |
2016-04-22 |
Adaptimmune Therapeutics plc. (4/22/16). "Press Release: Adaptimmune Appoints Leading Immunotherapy Experts from United States and Europe to Inaugural Scientific Advisory Board". Philadeliphia, PA & Oxford. |
2016-04-22 |
AstraZeneca plc. (4/25/16). "Press Release: Bevespi Aerosphere Approved by the US FDA for Patients with COPD". |
2016-04-25 |
TxCell S.A.. (4/25/16). "Press Release: TxCell and Ospedale San Raffaele Launch Collaboration for the Development of CAR-Tregs in Lupus Nephritis". Valbonne & Milan. |
2016-04-25 |
TxCell S.A.. (4/25/16). "Press Release: Letter to Shareholders – from Stéphane Boissel, CEO of TxCell April 25, 2016". Valbonne & Milan. |
2016-04-25 |
Eurofins. (4/25/16). "Press Release: Eurofins Reinforces Its Specialty Clinical Diagnostics Footprint by Acquiring PerkinElmer’s NTD Laboratory Services Business". |
2016-04-25 |
Eurofins. (4/25/16). "Press Release: Eurofins Achieves 48% Revenue growth and over 10% Organic Growth in Q1 2016". |
2016-04-25 |
PerkinElmer, Inc.. (4/25/16). "Press Release: PerkinElmer Sells NTD Laboratory Services Business to Eurofins Scientific". Waltham, MA. |
2016-04-25 |
Immunicum AB. (4/25/16). "Press Release: Immunicum Announces Fully Underwritten Rights Issue of about SEK 111 Million to Extend Phase II-Trial with New clinics in the US and to Initiate Clinical Trials in Melanoma in the US and in Sweden". |
2016-04-25 |
Wilex AG. (4/25/16). "Press Release: Wilex AG Successfully Completes Capital Increase". Munich. |
2016-04-25 |
AstraZeneca plc. (4/26/16). "Press Release: AstraZeneca Enters into US Licensing Agreement with Ironwood Pharmaceuticals for Lesinurad". |
2016-04-26 |
Evotec AG. (4/26/16). "Press Release: Evotec and Ex Scientia Announce Partnership to Discover Bispecific Small Molecule Immuno-oncology Therapeutics". Hamburg & Dundee. |
2016-04-26 |
Zymeworks Inc.. (4/26/16). "Press Release: Zymeworks and GSK Enter Second Strategic Collaboration to Develop and Commercialize Bi-Specific Antibodies". Vancouver. |
2016-04-26 |
Oxford Biomedica plc. (4/26/16). "Press Release: Oxford BioMedica Announces Stuart Henderson Appointed as a Non-executive Director". London. |
2016-04-26 |
Horizon Discovery Group plc. (4/26/16). "Press Release: Preliminary Results for the Year Ended 31 Dec 2015". Cambridge. |
2016-04-26 |
Alizé Pharma. (4/26/16). "Press Release: Alizé Pharma Reports Positive Results from Its Phase II Clinical Trial of AZP-531 in Prader-Willi Syndrome". Lyon. |
2016-04-26 |
Stratec Biomedical AG. (4/26/16). "Press Release: Stratec Reports on First Three Months of 2016". Birkenfeld. |
2016-04-26 |
Servier. (4/27/16). "Press Release: Patients with Advanced Metastatic Colorectal Cancer in Europe Now Have a New Treatment Option as Lonsurf (trifluridine/tipiracil) Receives EU Approval". Suresnes. |
2016-04-27 |
UBS AG. (4/27/16). "Press Release: UBS Raises Record $471m for Oncology Impact Fund". Zurich & Basel. |
2016-04-27 |
VTU Technology GmbH. (4/27/16). "Press Release: VTU Technology and Boehringer Ingelheim Strengthen Their Global Microbial Technology Collaboration". Grambach & Vienna. |
2016-04-27 |
Epigenomics AG. (4/27/16). "Press Release: Epigenomics Announces Commercial Launch of Epi proColon in the U.S.". Berlin & Germantown, MD. |
2016-04-27 |
OncoDNA S.A.. (4/27/16). "Press Release: OncoDNA Launches Its New Product OncoTRACE". |
2016-04-27 |
iTeos Therapeutics S.A.. (4/27/16). "Press Release: iTeos Therapeutics SA Today Announced the Appointment of Yves Mertens as Chief Financial Officer". Gosselies. |
2016-04-27 |
Editas Medicine, Inc.. (4/27/16). "Press Release: Editas Medicine to Present at Deutsche Bank 41st Annual Health Care Conference". Cambridge, MA. |
2016-04-27 |
Adaptimmune Therapeutics plc. (4/27/16). "Press Release: Adaptimmune to Present at the Deutsche Bank Securities 41st Annual Health Care Conference". |
2016-04-27 |
High-Tech Gründerfonds Management GmbH. (4/27/16). "Press Release: Bentekk GmbH Receives Seed Funding to Develop the Market with Gas Measurement Technology". |
2016-04-27 |
Illumina, Inc.. (4/27/16). "Press Release: Illumina to Webcast Live Presentation at the Bank of America Merrill Lynch Health Care Conference". San Diego, CA. |
2016-04-27 |
GlaxoSmithKline plc. (4/27/16). "Press Release: GSK Statement on Pneumococcal Vaccine Pricing". |
2016-04-27 |
Sanofi S.A.. (4/28/16). "Press Release: Sanofi Offers to Acquire Medivation for $52.50 per Share in Cash". Paris. |
2016-04-28 |
OBN (UK) Ltd.. (4/28/16). "Press Release: Elasmogen Winner of the Perfect Pitch at the 2016 BioTrinity Conference in London". London. |
2016-04-28 |
Eppendorf AG. (4/28/16). "Press Release: Eppendorf Continues Successful Development. Group Sales of €629.1 million (18.5% Growth in Sales) – Income from Operations of €119.3 million (19.0% EBIT Margin)". Hamburg. |
2016-04-28 |
Oncgnostics GmbH. (4/28/16). "Press Release: Oncgnostics GmbH Cooperates with Sayre Therapeutics in India". Bangalore & Jena. |
2016-04-28 |
BioQ Pharma Inc.. (4/28/16). "Press Release: BioQ Pharma Expands U.S. License and Supply Agreement to Commercialize Third Ready-to-Use Infusion Product". San Francisco, CA. |
2016-04-28 |
Oxford Biomedica plc. (4/28/16). "Press Release: Preliminary Results for the Year Ended 31 December 2015". Oxford. |
2016-04-28 |
Toximet Ltd.. (4/28/16). "Press Release: Bio-Check (UK) Acquire ToxiMet". |
2016-04-28 |
Sygnis AG. (4/28/16). "Press Release: Sygnis Reports Financial Results for Fiscal Year 2015". Madrid & Heidelberg. |
2016-04-28 |
Evotec AG. (4/28/16). "Press Release: Evotec to Present at Two Upcoming IR Conferences (USA)". Hamburg. |
2016-04-28 |
Glycotope GmbH. (4/29/16). "Press Release: Glycotope Appoints Dr. Alfredo Zurlo as Chief Medical Officer". Berlin. |
2016-04-29 |
4SC AG. (4/29/16). "Press Release: 4SC Sells Operations of Its Discovery Division [Ad hoc announcement according to $ 15 WpHG]". Planegg-Martinsried. |
2016-04-29 |
Ablynx N.V.. (4/29/16). "Press Release: Ablynx Announces Milestone in Drug Discovery Collaboration". Ghent. |
2016-04-29 |
Roche. (4/29/16). "Press Release: CHMP Recommends EU Approval for Roche’s Avastin in Combination with Tarceva for Patients with a Specific Type of Advanced Lung Cancer". Basel. |
2016-04-29 |
Roche. (4/29/16). "Press Release: CHMP Recommends EU Approval of Roche’s Gazyvaro for People with Previously Treated Follicular Lymphoma". Basel. |
2016-04-29 |
From »The Analytical Scientist« (Issue 40, May 2016). (5/16). "Towards Meritocracy (by Ellen Miseo)". |
2016-05-01 |
From »The Analytical Scientist« (Issue 40, May 2016). (5/16). "(I Love the Sound of) Breaking Glass. Is (Analytical) Science Still Sexist? (by Joanna Cummings)". |
2016-05-01 |
From »The Analytical Scientist« (Issue 40, May 2016). (5/16). "Making Great Strides (by Heather Brooke)". |
2016-05-01 |
From »The Analytical Scientist« (Issue 40, May 2016). (5/16). "Leaning In (by Mary Kate Donais)". |
2016-05-01 |
From »The Analytical Scientist« (Issue 40, May 2016). (5/16). "An Ongoing Effort (by Nicola Gaston)". |
2016-05-01 |
From »The Analytical Scientist« (Issue 40, May 2016). (5/16). "Beyond the »Old Boys Club« (by Ingeborg Petterson)". |
2016-05-01 |
From »The Analytical Scientist« (Issue 40, May 2016). (5/16). "On Balance (by Lisa Miller)". |
2016-05-01 |
Eppendorf AG. (5/2/16). "Press Release: The New Eppendorf Tubes 5.0 mL with Screw Cap". Hamburg. |
2016-05-02 |
Epigenomics AG. (5/2/16). "Press Release: China FDA Names Epigenomics’ Blood-based Septin9 Colorectal Cancer Test a Most Innovative Medical Product for 2015". Berlin & Germantown, MD. |
2016-05-02 |
Eppendorf AG. (5/2/16). "Press Release: Eppendorf and Bio-ITech Demonstrate Integrated Digital Lab Workflows with the ELN eLabJournal for the First Time at Analytica 2016". Hamburg. |
2016-05-02 |
Immunicum AB. (5/2/16). "Press Release: Immunicum Applies for Listing on the Nasdaq Stockholm Main Market". Gothenburg. |
2016-05-02 |
Oncurious N.V.. (5/2/16). "Press Release: Oncurious NV, BioInvent and NMTRC Initiating Phase I/IIa Study with TB-403 for the Treatment of Medulloblastoma". Leuven. |
2016-05-02 |
Werum IT Solutions AG. (5/2/16). "Press Release: Pharma Tech Firms Werum IT Solutions and Zenith Technologies Announce Global MES Partnership". Lüneburg. |
2016-05-02 |
Eppendorf AG. (5/2/16). "Press Release: Eppendorf Centrifuge 5920 R. The New Benchmark in Capacity and Performance". Hamburg. |
2016-05-02 |
NMI TT Pharmaservices. (5/2/16). "Press Release: Sentinel Oncology and NMI TT Pharmaservices Awarded Eurostars Grant for Development of a Novel Biomarker for Treatment of Fragile X Syndrome". Cambridge & Berlin. |
2016-05-02 |
Eppendorf AG. (5/2/16). "Press Release: Advanced Pipetting with Eppendorf’s New Multipettes/Repeaters Takes the Strain Out of Serial Dispensing". Hamburg. |
2016-05-02 |
Eurofins Scientific. (5/2/16). "Press Release: Eurofins Reinforces Its Environment Testing Footprint with the Acquisition of EAC Corp. in Japan". |
2016-05-02 |
Ideaya Biosciences, Inc.. (5/3/16). "Press Release: Ideaya Biosciences Raises $46 Million Series A and Recruits Leadership and Advisory Board". South San Francisco, CA & La Jolla, CA. |
2016-05-03 |
Biomax Informatics AG. (5/3/16). "Press Release: Biomax Informatics AG Launches the Next Generation of the BioRS Integration and Retrieval System". Planegg. |
2016-05-03 |
Uniqure N.V.. (5/3/16). "Press Release: Uniqure Appoints Paul Firuta as Chief Commercial Officer". Amsterdam. |
2016-05-03 |
MDxHealth S.A.. (5/3/16). "Press Release: MDxHealth Provides First Quarter 2016 Business Update. Revenue Increased 66% Over First Quarter 2015". Irvine, CA & Herstal. |
2016-05-03 |
MorphoSys AG. (5/3/16). "Press Release: MorphoSys AG Reports Results for the First Three Months of 2016. Financial Guidance 2016 Confirmed". |
2016-05-03 |
IMS Health Holdings Inc.. (5/3/16). "Press Release: IMS Health and Quintiles to Merge, Quintiles IMS to Become Industry-Leading Information and Technology-Enabled Healthcare Service Provider". Danbury, CT & Research Triangle Park, NC. |
2016-05-03 |
Ipsen S.A.. (5/3/16). "Press Release: Oncodesign and Ipsen Enter into a Strategic Partnership in Oncology and Oncodesign Joins Ipsen’s Paris-Saclay Campus". Paris & Dijon. |
2016-05-03 |
Orchard Therapeutics Ltd.. (5/3/16). "Press Release: Orchard Therapeutics Launches and Announces Academic Partnerships for Development of Transformative Gene Therapies". London. |
2016-05-03 |
Illumina, Inc.. (5/3/16). "Press Release: Illumina Reports Financial Results for First Quarter of Fiscal Year 2016". San Diego, CA. |
2016-05-03 |
Adaptimmune Therapeutics plc. (5/3/16). "Press Release: Adaptimmune to Present at the Bank of America Merrill Lynch 2016 Health Care Conference". Philadeliphia, PA & Oxford. |
2016-05-03 |
Dassault Systèmes S.A.. (5/3/16). "Press Release: European Spallation Source Chose Dassault Systèmes’ 3DExperience Platform to Develop the World’s Leading Neutron Research Center". Vélizy-Villacoublay. |
2016-05-03 |
Roche. (5/3/16). "Press Release: Roche Highlights Personalised Medicines and Cancer Immunotherapies at 2016 American Society of Clinical Oncology (ASCO) Annual Meeting". Basel. |
2016-05-03 |
Scienion AG. (5/4/16). "Press Release: New Tool Allows Scientists to Visualize »Nanoscale« Processes". Berlin & San Diego, CA. |
2016-05-04 |
Alacrita LLP. (5/4/16). "Press Release: Alacrita Builds Companion Diagnostic Consulting Practice". Cambridge, MA. |
2016-05-04 |
Innate Pharma S.A.. (5/4/16). "Press Release: First Quarter 2016 Report. Cash, Cash Equivalents and Financial Instruments of the Company Amounted to €255.8 Million". Marseille. |
2016-05-04 |
Ergomed plc. (5/4/16). "Press Release: Proposed Acquisition of Haemostatix Limited". London. |
2016-05-04 |
Vaximm AG. (5/4/16). "Press Release: Vaximm Initiates Phase 2a Study in Advanced Colorectal Cancer with Oral T-cell Vaccine VXM01". Basel & Mannheim. |
2016-05-04 |
MorphoSys AG. (5/4/16). "Press Release: MorphoSys to Present at Three Upcoming Conferences". |
2016-05-04 |
Editas Medicine, Inc.. (5/4/16). "Press Release: Editas Medicine Achieves Milestone Under Its Collaboration with Juno Therapeutics". Cambridge, MA. |
2016-05-04 |
Oryzon Genomics S.A.. (5/4/16). "Press Release: Oryzon Closes € 10.5 Million (12.1 M USD) Debt Financing". Barcelona & Cambridge, MA. |
2016-05-04 |